These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23971760)

  • 1. Rapid fecal calprotectin correlates with clinical and endoscopic severity of inflammatory bowel diseases.
    Tursi A; Elisei W; Giorgetti G; Picchio M; Brandimarte G
    Scand J Gastroenterol; 2013 Nov; 48(11):1359-60. PubMed ID: 23971760
    [No Abstract]   [Full Text] [Related]  

  • 2. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V; Chaparro M; Gisbert JP
    Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
    Røseth AG; Aadland E; Grzyb K
    Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calprotectin in feces a well-documented marker of gastrointestinal inflammation. Indicates disease intensity--normalization of values predict mucosal healing].
    Lasson A
    Lakartidningen; 2010 Oct 27-Nov 2; 107(43):2645-9. PubMed ID: 21137533
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
    Dig Dis Sci; 2017 Nov; 62(11):3123-3130. PubMed ID: 28948412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.
    van Rheenen PF
    Inflamm Bowel Dis; 2012 Nov; 18(11):2018-25. PubMed ID: 22275341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
    Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
    Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal calprotectin concentrations in gastrointestinal diseases.
    Wang S; Wang Z; Shi H; Heng L; Juan W; Yuan B; Wu X; Wang F
    J Int Med Res; 2013 Aug; 41(4):1357-61. PubMed ID: 23723365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-calprotectin and Blood Markers Correlate to Quality of Life in Pediatric Inflammatory Bowel Disease.
    Carlsen K; Jakobsen C; Kallemose T; Paerregaard A; Riis LB; Munkholm P; Wewer V
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):539-545. PubMed ID: 28169974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The semi-quantitative calprotectin rapid test--is it useful in inflammatory bowel disease?
    Dranga M; Dumitrescu G; Badea M; Blaj A; Mihai C; Prelipcean CC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):761-5. PubMed ID: 23272524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Calprotectin Measured By Patients at Home Using Smartphones--A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease.
    Vinding KK; Elsberg H; Thorkilgaard T; Belard E; Pedersen N; Elkjaer M; Marker D; Carlsen K; Burisch J; Munkholm P
    Inflamm Bowel Dis; 2016 Feb; 22(2):336-44. PubMed ID: 26535869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease.
    Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
    Eur J Clin Invest; 2016 Oct; 46(10):825-32. PubMed ID: 27438629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy.
    Egea-Valenzuela J; Alberca-de-Las-Parras F; Carballo-Álvarez F
    Rev Esp Enferm Dig; 2015 Apr; 107(4):211-4. PubMed ID: 25824919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion.
    Rogler G; Aldeguer X; Kruis W; Lasson A; Mittmann U; Nally K; Peyrin-Biroulet L; Schoepfer A; Vatn M; Vavricka S; Logan R
    J Crohns Colitis; 2013 Sep; 7(8):670-7. PubMed ID: 23517932
    [No Abstract]   [Full Text] [Related]  

  • 18. Faecal markers of gastrointestinal inflammation.
    Sherwood RA
    J Clin Pathol; 2012 Nov; 65(11):981-5. PubMed ID: 22813730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Fecal Calprotectin Testing Predicts Mucosal Healing Better than C-reactive Protein and Serum Tumor Necrosis Factor α in Patients with Ulcerative Colitis.
    Voiosu T; Benguş A; Bălănescu P; Dinu R; Voiosu A; Băicuş C; Mateescu B
    Rom J Intern Med; 2015; 53(3):253-60. PubMed ID: 26710501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.
    Kopylov U; Rosenfeld G; Bressler B; Seidman E
    Inflamm Bowel Dis; 2014 Apr; 20(4):742-56. PubMed ID: 24562174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.